<DOC>
	<DOCNO>NCT00185458</DOCNO>
	<brief_summary>The study design look transfer use LNG IUS contraception , reproductive age use endometrial protection menopausal age . The main area interest study pattern vaginal bleeding occurs .</brief_summary>
	<brief_title>Assessment Transfer Using Levonorgestrel Intrauterine System ( LNG IUS ) Contraceptive Using Part Hormone Replacement Therapy ( HRT ) .</brief_title>
	<detailed_description>The study previously post Schering AG , Germany . Schering AG , Germany rename Bayer HealthCare AG , Germany . Bayer HealthCare AG , Germany sponsor trial .</detailed_description>
	<mesh_term>Levonorgestrel</mesh_term>
	<criteria>Women intact uterus , regular menstrual cycle previous current climacteric symptom . Pregnancy lactation . Previous pelvic infection . Abnormal bleeding . Abnormal uterine cavity . Uterine polyp . Genital cancer . Liver diseases . Alcoholism drug abuse .</criteria>
	<gender>Female</gender>
	<minimum_age>46 Years</minimum_age>
	<maximum_age>51 Years</maximum_age>
	<verification_date>November 2013</verification_date>
</DOC>